Premium
Crohn's disease initially presenting with oral manifestations and managed with ustekinumab: A case report
Author(s) -
Alrashdan Mohammad S.,
Safadi Rima A.
Publication year - 2021
Publication title -
special care in dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 41
eISSN - 1754-4505
pISSN - 0275-1879
DOI - 10.1111/scd.12598
Subject(s) - medicine , ustekinumab , crohn's disease , dermatology , disease , crohn disease , treatment modality , inflammatory bowel disease , intensive care medicine , adalimumab
Abstract Oral Crohn's disease (OCD) refers to the spectrum of oral manifestations seen in Crohn`s disease (CD) patients and could precede other signs of the disease elsewhere, which requires dental practitioners to be vigilant for oral mucosal changes that may accompany such systemic disorders. Classical treatment modalities are based on the use of corticosteroids, immune‐modulators and more recently, biologics. Ustekinumab is a novel agent from this last group that has shown efficacy in a limited number of case reports. A case of a debilitating CD presenting initially with oral manifestations and ultimately managed with ustekinumab is reported.